AVITIDE, INC.
Profile
Company Names
AVITIDE, INC.
Addresses
16 CAVENDISH COURT, LEBANON, NH 03766
7 LUCENT DRIVE, LEBANON, NH 03766
Phone Numbers
(603)965-2100
(641) 420-5991
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$40,928,953.00
Number of Funding Rounds:
7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-10-15
$9,999,796.00
$9,999,796.00
$0.00
Equity
6
2018-08-09
$6,212,290.00
$6,212,290.00
$0.00
Equity
5
2017-12-18
$3,999,983.00
$3,999,983.00
$0.00
Equity
4
2017-06-13
$11,999,962.00
$11,999,962.00
$0.00
Equity
3
2015-07-23
$3,831,920.00
$7,663,840.00
$3,831,920.00
Equity
2
2014-05-27
$3,435,003.00
$3,435,003.00
$0.00
Equity
1
2013-03-04
$1,449,999.00
$1,449,999.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERRIK
ANDERSON
DIRECTOR
AVITIDE, INC.
| KAIROS BIOLOGICS FOUNDATION LLC
| GREEN D FOUNDERS FUND 2014-I, LLLP
| COMPASS THERAPEUTICS LLC
| GTP AW FUND II, LLC
| UDH MSPV I LLC
| UDH MSPV II LLC
| VERNAL BIOSCIENCES, INC.
| WHEELER BIO, INC.
| MYTIDE THERAPEUTICS, INC.
| CANTAI THERAPEUTICS, INC.
| ALUMNI VENTURES GROUP LLC
| AAKHA BIOLOGICS, INC.
| ANGIEX, INC.
| 82VS SEED FUND, LP
PHILIP
FERNEAU
DIRECTOR
TILLMAN
GERNGROSS
DIRECTOR, EXECUTIVE OFFICER
COLIN
GREENSPON
DIRECTOR
RISHI
GUPTA
DIRECTOR
GELESIS INC
| SIENTRA, INC.
| AVITIDE, INC.
| SYMBIOMIX THERAPEUTICS, LLC
| DIMENSION THERAPEUTICS, INC.
| MEVES PHARMACEUTICALS, INC.
| ATTENUA, INC.
| TURNSTONE BIOLOGICS CORP.
| GOLDEN TEAK CAPITAL L.P.
| NEUROPACE INC
| VERONA PHARMA PLC
| CHARM THERAPEUTICS INC.
| DELFI DIAGNOSTICS, INC.
| AER THERAPEUTICS, INC.
| HELICORE BIOVENTURES I, INC.
| ENLIVEN THERAPEUTICS, INC.
| WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
CLAUDIO
NESSI
DIRECTOR
IAN
RATCLIFFE
DIRECTOR
GLOBAL CELL SOLUTIONS INC
| STEMGENT INC
| STEMGENT, INC.
| ENZYMATICS INC
| FRESHAIR SENSOR LLC
| MITRA RXDX, INC.
| AGILIS BIOTHERAPEUTICS, INC.
| AVITIDE, INC.
| ACESSA HEALTH INC.
| SANDS CAPITAL PRIVATE GROWTH FUND III, L.P.
| NANOVIEW DIAGNOSTICS INC.
| SANDS CAPITAL VENTURES FUND-SLK, L.P.
| TECKRO, INC.
| SANDS CAPITAL PRIVATE GROWTH FUND III-DC, L.P.
| SCM-S72-1, LLC
| NANOVIEW BIOSCIENCES, INC.
| VITARA BIOMEDICAL, INC.
| SANDS CAPITAL GLOBAL VENTURE FUND III, L.P.
MICHAEL
ROSS
DIRECTOR
CERVILENZ INC
| JUVARIS BIO THERAPEUTICS INC
| IKANO THERAPEUTICS INC.
| ADIMAB, INC.
| SV LIFE SCIENCES FUND V LP
| LINK MEDICINE CORP
| CATABASIS PHARMACEUTICALS INC
| SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.
| ARSANIS, INC.
| BALANCE HEALTH CORP
| ABCAM PLC
| ADIMAB, LLC
| AVITIDE, INC.
| OPHTHOTECH CORP.
| THESAN PHARMACEUTICALS, INC.
| SV LIFE SCIENCES FUND VI, L.P.
| DECIPHERA PHARMACEUTICALS, LLC
| DEMENTIA DISCOVERY LP
| AMERICLEAN HOLDINGS LLC
| SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.
| FRESCO FOODS, INC.
| SUTRO BIOPHARMA INC
| RIBOMETRIX, INC.
| JASON RYAN
| NICE RECOVERY SYSTEMS LLC
| THERINI BIO, INC.
| MAINE CRISP COMPANY, LLC
| JOSEPH VENTURES ALLIUM I LLC, SERIES A
| XILIO THERAPEUTICS, INC.
| JOSEPH VENTURES ALLIUM I LLC, SERIES C
| SV LIFE SCIENCES FUND IV CF, L.P.
| ANDOVIA INC.
| TREX HOLDINGS INC.
| DUALITAS THERAPEUTICS, INC.
AJAY
ROYAN
DIRECTOR
POLLEN, INC.
| AURIS SURGICAL ROBOTICS, INC.
| SILVERRAIL TECHNOLOGIES, INC.
| APPDIRECT, INC.
| DOUBLEDUTCH, INC.
| FRACTYL LABORATORIES INC.
| HELION ENERGY, INC.
| MITHRIL II LP
| SPACEFLIGHT INDUSTRIES, INC.
| AVITIDE, INC.
| AURIS HEALTH, INC.
| NEOCIS, INC.
| NUVIA, INC.
| ADAGIO THERAPEUTICS, INC.
| FRACTYL HEALTH, INC.
| GREY ORANGE INTERNATIONAL INC.
| ANKYRA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
